Court of Appeals for the Federal Circuit
GPTKB entity
Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:United_States_District_Court
|
| gptkbp:appeals_to |
gptkb:Court_of_Federal_Claims
gptkb:Court_of_International_Trade gptkb:United_States_Patent_and_Trademark_Office |
| gptkbp:decided_by |
reviewed by the Supreme Court of the United States
|
| gptkbp:established |
gptkb:1982
|
| gptkbp:headquarters |
gptkb:Washington,_D._C.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Court of Appeals for the Federal Circuit
|
| gptkbp:judges |
gptkb:12
gptkb:Kimberly_A._Moore |
| gptkbp:jurisdiction |
patent law
|
| gptkbp:notable_case |
gptkb:Microsoft_Corp._v._i4i_Limited_Partnership
gptkb:Association_for_Molecular_Pathology_v._Myriad_Genetics,_Inc. gptkb:Bilski_v._Kappos gptkb:Alden_v._Maine gptkb:In_re_Bilski gptkb:e_Bay_Inc._v._Merc_Exchange,_L._L._C. In re: Tam In re: Acorda Therapeutics, Inc. In re: Alden v. Maine. In re: Amgen Inc. In re: Bilski. In re: Biogen Idec Inc. In re: CRFD Research, Inc. In re: Celgene Corporation. In re: DBC, LLC. In re: Eli Lilly and Company. In re: Genentech, Inc. In re: Gilead Sciences, Inc. In re: Google Inc. In re: Hynix Semiconductor Inc. In re: MCM Portfolio LLC In re: MCM Portfolio LLC. In re: Merck & Co., Inc. In re: Microsoft Corp. v. i4i Limited Partnership. In re: Mylan Pharmaceuticals Inc. In re: Novartis AG. In re: Regeneron Pharmaceuticals, Inc. In re: Seagate Technology, LLC In re: Seagate Technology, LLC. In re: Tam. In re: Teva Pharmaceuticals USA, Inc. In re: Vanda Pharmaceuticals Inc. In re: Association for Molecular Pathology v. Myriad Genetics, Inc. |
| gptkbp:precedent |
binding on all lower courts
|
| gptkbp:bfsParent |
gptkb:U._S._Court_of_Appeals_system
|
| gptkbp:bfsLayer |
6
|